For US Health Care Professionals Only
Meet Steve, Jesús, and Tom, 3 Novo Nordisk Representatives who work directly with the hemophilia community. Hear about how Novo Nordisk has committed to addressing the community’s unique needs and how much they enjoy their role in helping to improve the lives of people living with hemophilia.
Meet Steve, Jesús, and Tom, 3 Novo Nordisk Representatives who work directly with the hemophilia community. Hear about how Novo Nordisk has committed to addressing the community’s unique needs and how much they enjoy their role in helping to improve the lives of people living with hemophilia.
Team Novo8™ is a group of patients who switched to Novoeight® and spend their time helping others with hemophilia A. Hear more about their mission, and how your patients may benefit from their experiences.
Novoeight® (antihemophilic factor, recombinant) is indicated for use in adults and children with hemophilia A for on-demand treatment and control of bleeding episodes, perioperative management, and routine prophylaxis to reduce the frequency of bleeding episodes.
